Skip to main content
OpenTrials
Completed

NCT Number: NCT01978925

Pharmaceutical Care in Emergency Department

The purpose of this study is to evaluate the effectiveness of pharmaceutical care, compared to usual care, in patient discharge in an emergency department in patients with hypertension and/or diabetes mellitus type 2.

Completed

Looking for future studies?

Notify Me

Key information

About this study

This is a randomized controlled, single-center study, with blinding of outcome assessors. A pilot study with ten patients was previously conducted in order to test study logistics and data collection instruments. Participants will be recruited from a public ED at Restinga district in Porto Alegre, southern Brazil.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Blood pressure inadequate control (systolic blood pressure ≥ 160 or diastolic blood pressure ≥ 100 mmHg) or
  • Diabetes mellitus inadequate Control( ≥ 200 mg/dL) or hypoglycemia moderate or severe
  • Be referred to clinical care.

Exclusion criteria

  • < 18 years
  • Not resident of Porto Alegre
  • Diabetes mellitus type I
  • Unable to answer the questionnaire or to sign the informed consent form
  • Hospital admission
  • Death

Treatment and study plan

Pharmaceutical care

Other

The clinical pharmacist will provide a structured 30-minute intervention for enhancing their medication adherence.

The recommendations include: discussion on hypertension and/or diabetes, risk of complications, prescribed drug therapy, correct use of medications and proper dosage, possible adverse effects, route of administration, schedule of administration and correct storage. The pharmacist will also emphasize the importance of lifestyle modifications. Printed educational material, with information on hypertension and/ or diabetes medications, including suggested lifestyle interventions was prepared to assist in the intervention and will be handed to patients in the end of the session.

Primary outcomes

  1. Medication Adherence

    Time frame: Two months

    Outcome of interest: High Adherence According to the Brief Medication Questionnaire and Morisky-Green Test

Secondary outcomes

  1. Blood Pressure Control

    Time frame: Two months

  2. Glycated hemoglobin (HbA1C) for diabetic patients

    Time frame: two months

  3. Quality of Life

    Time frame: Two months

Other outcomes

  1. Fasting plasma glucose for diabetic patients

    Time frame: Two months

Sponsors and collaborators

Lead sponsor

Hospital Moinhos de Vento

Other

Collaborators

  • Ministry of Health, Brazil

Registry information

Official study title

Effectiveness Pharmaceutical Care at Discharge in the Emergency Department: a Randomized Controlled Trial

Acronym: AMPaRAR

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Nov 8, 2013
Registry last updated
May 20, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.